Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions - Poll - MDSpire

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions

  • By

  • Maen Abdelrahim

  • Abdullah Esmail

  • Bandar Al-Judaibi

  • Ola Khorshid

  • Bhoori Sherrie

  • Vincenzo Mazzaferro

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions

  • by Maen Abdelrahim, Abdullah Esmail, Bandar Al-Judaibi, Ola Khorshid, Bhoori Sherrie, Vincenzo Mazzaferro

  • May 28, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review